Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1994;14:686-693

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Green, D.
Right arrow Articles by Liu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, D.
Right arrow Articles by Liu, K.

Arteriosclerosis and Thrombosis, Vol 14, 686-693, Copyright © 1994 by American Heart Association


ARTICLES

Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study

D Green, KJ Ruth, AR Folsom and K Liu
Department of Medicine, Northwestern University Medical School, Chicago, Ill.

Elevated levels of factor VII (FVII) and fibrinogen (Fb) have been reported as risk factors for coronary heart disease in middle-aged and older adults. The purpose of this study was to determine whether increased levels of these and other hemostatic factors (FVIII, von Willebrand factor [vWF]) were associated with other coronary risk factors in young adults participating in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Hemostatic factors were measured in 1724 participants aged 23 to 35 years who were roughly balanced by sex and race (black/white). Fb was greater in women than men (black, 288 versus 253 mg/dL; white, 267 versus 240 mg/dL; overall P < .05 by Scheffe multiple-comparison test), and FVIII and vWF were higher in blacks than in whites (FVIII in men, 103% versus 88%, and in women, 104% versus 91%; vWF in men, 114% versus 98%, and in women, 117% versus 99%; P < .05). The latter factors were lower in those with blood group O, but within each blood group (except group A), blacks had significantly higher levels of FVIII and vWF. Fb was positively correlated with body mass index (r = .27 to .48, P < .001), total cholesterol (r = .13 to .17, P < .05), and low-density lipoprotein cholesterol (r = .15 to .22, P < .01) in all groups and with blood pressure, triglycerides, and cigarette smoking in white men. FVII correlated positively with cholesterol (r = .12 to .29, P < .05) and triglycerides (r = .23 to .32, P < .001) in all groups and with low- density lipoprotein in whites.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
BloodHome page
K. R. Viel, D. K. Machiah, D. M. Warren, M. Khachidze, A. Buil, K. Fernstrom, J. C. Souto, J. M. Peralta, T. Smith, J. Blangero, et al.
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels
Blood, May 1, 2007; 109(9): 3713 - 3724.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Hozawa, D. R. Jacobs Jr., M. W. Steffes, M. D. Gross, L. M. Steffen, and D.-H. Lee
Relationships of Circulating Carotenoid Concentrations with Several Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction: The Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) Study
Clin. Chem., March 1, 2007; 53(3): 447 - 455.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
N. C. Sousa, J. M. Anicchino-Bizzacchi, M. F. Locatelli, V. Castro, and M. L. Barjas-Castro
The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor
Haematologica, February 1, 2007; 92(2): 236 - 239.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Shankar, J. J. Wang, E. Rochtchina, and P. Mitchell
Positive Association Between Plasma Fibrinogen Level and Incident Hypertension Among Men: Population-Based Cohort Study
Hypertension, December 1, 2006; 48(6): 1043 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
B. Thyagarajan, D. R Jacobs, G. G Apostol, L. J Smith, C. E Lewis, and O D. Williams
Plasma fibrinogen and lung function: the CARDIA Study
Int. J. Epidemiol., August 1, 2006; 35(4): 1001 - 1008.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. H. Criqui, V. Vargas, J. O. Denenberg, E. Ho, M. Allison, R. D. Langer, A. Gamst, W. P. Bundens, and A. Fronek
Ethnicity and Peripheral Arterial Disease: The San Diego Population Study
Circulation, October 25, 2005; 112(17): 2703 - 2707.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. A. Bazzano, J. He, P. Muntner, S. Vupputuri, and P. K. Whelton
Relationship between Cigarette Smoking and Novel Risk Factors for Cardiovascular Disease in the United States
Ann Intern Med, June 3, 2003; 138(11): 891 - 897.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. J. Tegos, E. Kalodiki, M. M. Sabetai, and A. N. Nicolaides
The Genesis of Atherosclerosis and Risk Factors: A Review
Angiology, February 1, 2001; 52(2): 89 - 98.
[Abstract] [PDF]


Home page
CirculationHome page
J. J. Stec, H. Silbershatz, G. H. Tofler, T. H. Matheney, P. Sutherland, I. Lipinska, J. M. Massaro, P. F.W. Wilson, J. E. Muller, and R. B. D'Agostino Sr
Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population
Circulation, October 3, 2000; 102(14): 1634 - 1638.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. F. Bielak, G. G. Klee, P. F. Sheedy II, S. T. Turner, R. S. Schwartz, and P. A. Peyser
Association of Fibrinogen With Quantity of Coronary Artery Calcification Measured by Electron Beam Computed Tomography
Arterioscler Thromb Vasc Biol, September 1, 2000; 20(9): 2167 - 2171.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. P. Kohler and P. J. Grant
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
N. Engl. J. Med., June 15, 2000; 342(24): 1792 - 1801.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. J. Siegel, M. B. Sholar, J. H. Mendelson, S. E. Lukas, M. J. Kaufman, P. F. Renshaw, J. C. McDonald, K. B. Lewandrowski, F. S. Apple, J. J. Stec, et al.
Cocaine-Induced Erythrocytosis and Increase in von Willebrand Factor: Evidence for Drug-Related Blood Doping and Prothrombotic Effects
Arch Intern Med, September 13, 1999; 159(16): 1925 - 1929.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. L. Archer, D. Green, M. Chamberlain, A. R. Dyer, and K. Liu
Association of Dietary Fish and n-3 Fatty Acid Intake With Hemostatic Factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study
Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1119 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Green, M. A. Chamberlain, K. J. Ruth, A. R. Folsom, and K. Liu
Factor VII, Cholesterol, and Triglycerides: The CARDIA Study
Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 51 - 55.
[Abstract] [Full Text]


Home page
CirculationHome page
M. W. Mansfield, D. M. Heywood, and P. J. Grant
Circulating Levels of Factor VII, Fibrinogen, and von Willebrand Factor and Features of Insulin Resistance in First-Degree Relatives of Patients With NIDDM
Circulation, November 1, 1996; 94(9): 2171 - 2176.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. S. Sharp, R. D. Abbott, C. M. Burchfiel, B. L. Rodriguez, R. P. Tracy, K. Yano, and J. D. Curb
Plasma Fibrinogen and Coronary Heart Disease in Elderly Japanese-American Men
Arterioscler Thromb Vasc Biol, February 1, 1996; 16(2): 262 - 268.
[Abstract] [Full Text]